![]() |
|
|
Vol. 58, Issue 6, 1333-1340, December 2000
Department of Cardiovascular Physiology, University of Goettingen, Germany (A.H.W., D.G., M.C., M.H.); and Institute of Physiological Chemistry and Pathobiochemistry, University of Mainz, Mainz, Germany (C.S.)
| |
Abstract |
|---|
|
|
|---|
Endothelin-1 is not only a powerful vasoconstrictor but also a
potent mitogen for vascular smooth muscle cells (SMC), acting through
both the endothelin-A and endothelin-B receptor (ETB-R). Although vascular SMC are known to express the ETB-R, its
transcriptional regulation has not been studied thus far. Here we
demonstrate that the potent inhibitor of nuclear factor
B
activation, pyrrolidine dithiocarbamate (PDTC; 30-100 µM), induces
de novo ETB-R expression in rat aortic and mesenteric
cultured SMC. Electrophoretic mobility shift analyses revealed that
besides inhibition of nuclear factor
B, PDTC enhances activator
protein-1 (AP-1), CCAAT/enhancer-binding protein (C/EBP), and GATA-2
activity in these cells. Preincubation of PDTC-stimulated cells with
appropriate decoy oligodeoxynucleotides confirmed the involvement of
these three transcription factors, namely that of AP-1, in
ETB-R expression. The stimulatory effect of PDTC on
ETB-R expression was also confirmed functionally by monitoring an enhanced ET-1-induced apoptosis in PDTC-treated cells
that was sensitive to the ETB-R antagonist, BQ788. Taken together, these findings demonstrate that C/EBP, GATA-2, and in particular AP-1 can control ETB-R expression in vascular
SMC. They further support the notion that ETB-R expression
in these cells may play an important role in cardiovascular
complications, such as restenosis following angioplasty that in the
early phase is characterized by prominent SMC apoptosis.
| |
Introduction |
|---|
|
|
|---|
The
endothelins constitute a family of three closely related peptides
(ET-1, ET-2, and ET-3) with diverse physiological and pathophysiological actions ranging from embryogenesis to heart failure.
In the cardiovascular system, ET-1 is the main representative of these
21 amino acid peptides. Predominantly formed by endothelial cells
lining the luminal surface of the blood vessels, ET-1 is not only a
powerful vasoconstrictor, but also a potent mitogen for vascular smooth
muscle cells (SMC). It is derived from a 212 amino acid precursor,
preproendothelin-1, that is sequentially processed to big ET-1 and ET-1
by a furin-like protease and one or several endothelin-converting
enzymes (Parris and Webb, 1997
; Schiffrin et al., 1997
). ET-1 exerts
its biological effects mainly through activation of two types of seven
transmembrane-spanning G protein-coupled receptors, designated
ETA-R and ETB-R. Although SMC express both types of receptors, ETA-R
activation appears to predominantly modulate SMC tone and proliferation
in arteries, whereas in veins ET-1 seems to exert these effects
primarily through activation of the ETB-R
(Douglas and Ohlstein, 1997
). Endothelial cells also express an
ETB-R, the activation of which promotes the
release of nitric oxide and prostacyclin, thereby potentially limiting
an excessive ETA-R and/or
ETB-R-mediated, ET-1-induced vasoconstriction.
The development of specific endothelin receptor antagonists has
provided some important insights into the pathophysiological significance of the endothelin system in cardiovascular disease (Kirchengast and Munter, 1999
). Thus, ET-1 may contribute to the intimal hyperplasia of venous bypass grafts through activation of the
ETA-R (Dashwood et al., 1998
) and/or
ETB-R (Porter et al., 1998
). Moreover, an
increased synthesis of ET-1 (Wang et al., 1996
) with consecutive
activation of the ETA-R and/or
ETB-R (Douglas et al., 1995
; Tsujino et al.,
1995
) has been implicated in restenosis following percutaneous
transluminal coronary angioplasty (PTCA). Unfortunately, most of the
endothelin receptor antagonists developed thus far seem to encounter
toxicological problems when administered to patients over a prolonged
period of time. Therefore, elucidating the transcriptional mechanisms
involved in endothelin receptor expression may provide a novel approach
to suppress the activity of the endothelin system in the aforementioned
cardiovascular complications.
Recent progress in molecular biology has spurred the development of new
techniques for specifically inhibiting expression of a target gene.
Antisense oligodeoxynucleotides (ODN) are single-stranded synthetic DNA
molecules that after internalization, a process which is dependent on
the sequence of the ODN (Etore et al., 1998
), hybridize with the
expressed mRNA of the target gene, hence preventing its translation
(Phillips and Gyurko, 1997
). A related powerful tool to prevent
transcription of a target gene is the transfection of cells with
double-stranded phosphorothioate-stabilized decoy ODN (Morishita et
al., 1998
). After entering the cells, these decoy ODN scavenge
endogenous transcription factors, thereby preventing them from binding
to the promoter of the target gene and effectively suppressing mRNA
synthesis. In addition, decoy ODN can be used to directly study the
transcriptional control of a gene of interest in cultured cells as well
as in native cells in situ. By employing this technique, for example,
cis-elements regulating basal transcription of the
ETA-R gene in a rat SMC line have recently been
identified (Yamashita et al., 1998
).
In the present study we have used the decoy ODN technique in combination with electrophoretic mobility shift analysis (EMSA) to identify transcription factors involved in ETB-R expression in cultured SMC from the aorta and mesenteric vascular bed of the rat.
| |
Materials and Methods |
|---|
|
|
|---|
Cell Culture.
SMC were isolated from the aorta of male
Wistar rats (250-300 g body weight) by using the explant technique
essentially as described (Krzesz et al., 1999
). They were seeded into
collagen type 1 or gelatin-coated 60-mm Petri dishes for EMSA and
Western blot analysis or into 6-well plates for RT-PCR analysis (2 mg/ml collagen or gelatin in 0.1 M HCl for 30 min at ambient
temperature). All incubations were performed in Waymouth medium
containing 10% fetal bovine serum (FBS; Life Technologies, Karlsruhe,
Germany) with SMC grown to at least 80% confluence. Incubations were
terminated by washing the cells with Hanks' balanced salt solution
(HBSS) followed by mRNA or protein extraction. Cell viability was
assessed by light microscopy as well as by a colorimetric assay with
the tetrazolium salt 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl
tetrazolium bromide (MTT; Denizot and Lang, 1986
).
-actin as
described (Krzesz et al., 1999RT-PCR Analysis.
Total RNA was isolated from the SMC by
solid-phase extraction with the RNeasy kit from Qiagen (Hilden,
Germany). Reverse transcription and polymerase chain reaction were
performed essentially as described previously (Krzesz et al., 1999
).
Amplification of elongation factor 2 (EF-2) cDNA served as an internal
standard. The following primers with the respective GenBank
accession number, position of the PCR product in the coding sequence,
and predicted size were used for amplification: ETA-R
(M60786, position 713-1258, 546 bp) 5'-TTCGTCATGGTACCCTTCGA-3' (sense)
and 5'-GATACTCGTTCCATTCATGG-3' (antisense); ETB-R (X57764,
position 1216-1689, 474 bp) 5'-TTCACCTCAGCAGGATTCTG-3' (sense) and
5'-AGGTGTGGAAAGTTAGAACG-3' (antisense); vascular cell adhesion
molecule-1 (VCAM-1; M84488, position 829-1933, 1105 bp)
5'-TGGAGCAAGAAATTAGATAATGG-3' (sense) and 5'-CACATGTACAGGAGATGATGA-3' (antisense); inducible nitric-oxide synthase (iNOS; D44591, position
22-848, 827 bp) 5'-ATGGCTTGCCCCTGGAAGTTTCTC-3' (sense) and
5'-CCTCTGATGGTGCCATCGGGCATCTG-3' (antisense); EF-2 (Z11692, position
1990-2207, 218 bp) 5'-GACATCACCAAGGGT-GTGCAG-3' (sense) and
5'-GCGGTCAGCACACTGGCATA-3' (antisense).
Western Blot Analysis.
Analysis of ETB-R protein
expression in the cultured smooth muscle cells was performed as
described (Hecker et al., 1994
) with the modification that the whole
cell homogenate was additionally treated for 15 min with 0.5% (w/v)
CHAPS at 0-4°C to enrich the membrane-bound ETB-R
protein in the 10,000g supernatant. Protein extracts
(10-50 µg of protein per lane) were separated by denaturing 10%
polyacrylamide gel electrophoresis in the presence of SDS according to
standard protocols and then transferred to a BioTrace polyvinylidene
fluoride transfer membrane (Pall Corporation, Roßdorf, Germany).
Transferred proteins were probed by an ETB-R-specific antiserum (
-CLK23; Cramer et al., 1997
) at a dilution of 1:2500. Visualization of the protein bands was achieved by using a secondary anti-rabbit antibody conjugated to horseradish peroxidase (1:3000 dilution; Sigma-Aldrich, St. Louis, MO), and the chemiluminescence detection method (SuperSignal chemiluminescent substrate; Pierce Chemical, Rockford, IL) was used followed by exposure to an
autoradiography film Hyperfilm MP (Amersham Pharmacia Biotech,
Buckinghamshire, England). Thereafter, the loading and transfer of
equal amounts of protein in each line was verified by staining of the
protein bands on the transfer membrane with India Ink followed by densitometry.
EMSA.
Nuclear extracts from the cultured SMC were prepared
as described previously (Krzesz et al., 1999
). The
double-stranded gel shift oligonucleotides (Santa Cruz Biotechnology,
Heidelberg, Germany) for activator protein-1 (AP-1,
5'-CGCTTGATGACTCAGCCGGAA-3'); CCAAT/enhancer-binding protein (C/EBP,
5'-TGCAGATTGCGC-AATCTGCA-3'); nuclear factor
B (NF-
B,
5'-AGTTGAGGGGACTTTCCCAGGC-3'); and GATA-2 (5'-CACTTGATAACAGAAAGTGATAACTCT-3') were end-labeled with
[
-32P]ATP by using the 5'-end-labeling kit from
Amersham Pharmacia Biotech (Freiburg, Germany). Typically the binding
mixture contained 3 to 10 µg of nuclear extract, 10,000 to
20,000 cpm of the 32P-labeled oligonucleotide probe (0.5 ng), 1 µg of poly[d(I-C)], and 1.33 mM
D,L-dithiothreitol in a total volume of 15 µl of
binding buffer. After 30 min at room temperature, the DNA-protein
complexes were resolved by nondenaturing 4% polyacrylamide gel
electrophoresis. The gel was dried and the 32P-labeled
protein-DNA complexes visualized by autoradiography. The specificity of
the binding reaction was monitored by performing the assay in parallel
with the same samples in the presence of a 100- to 1000-fold excess of
the nonlabeled oligonucleotide. For supershift analyses, 1.0 to 2.0 µl of the appropriate gel supershift antibody (200 µg/0.1 ml, Santa
Cruz Biotechnology) per 6.0 to 7.0 µl of nuclear extract (3-10 µg
of protein) were preincubated overnight at 4°C or at room temperature
for 60 min before the EMSA was performed.
Reporter Gene Analysis.
The pAP-1(PMA)-TA-Luc vector
(CLONTECH, Heidelberg, Germany) was used to show the activation of the
transcription factor AP-1 by PDTC. The pCMV TK luc+ expression vectors
(GenBank accession no. AF027129) containing the
168-bp fragment of
the rat preproendothelin-1 promoter as well as the control vectors with
and without the CMV promoter were prepared as described (Paul et al.,
1995
). Cotransfections for normalization of transfection efficacy were
performed with the SV40/
-galactosidase expression vector pUC19
(GenBank accession no. M77789). For transfection, 50% confluent rat
SMC were incubated with 1.5 µg of plasmid DNA and 18 µl of
Effectene (Qiagen, Hilden, Germany) for 6 h; thereafter the medium
was replaced and the cells cultured until they attained 80% confluence
(usually after 18-24 h). They were then incubated with 10 to 100 µM
PDTC or 0.1 µM phorbol 12-myristate 13-acetate (PMA) for 6 h.
Luciferase and
-galactosidase activities in the cell lysates were
determined by using corresponding chemiluminescence and photometric
assay kits (Promega, Mannheim, Germany).
Decoy Oligodeoxynucleotide Technique.
Double-stranded
ODN were prepared from complementary single-stranded
phosphorothioate-bonded ODN obtained from Eurogentec (Köln,
Germany) by melting at 95°C for 5 min followed by a cool-down phase
of 3 to 4 h at ambient temperature. The efficiency of the hybridization reaction was verified with 2.5% agarose gel
electrophoresis and usually found to exceed 85%. The sequences of the
single-stranded ODN were as follows (underlined letters denote
phosphorothioate-bonded bases): AP-1,
CGCTTGATGACTCAGCCGGAA; AP-1mut,
CGCTTGATTACTTAGCCGGAA; C/EBP,
TGCAGATTGCGCAATCTGCA; C/EBPmut,
TGCAGAGACTAGTCTCTGCA; NF-
B, AGTTGAGGGGACTTTCCCAGGC; GATA-2,
CACTTGATAACA-GAAAGTGATAACTCT. On the basis of
previous EMSA and RT-PCR analyses, the maximally effective
concentration and the optimal preincubation time for all decoy ODN in
the cultured SMC were determined to be 10 µM and 4 h.
Transfection of the decoy ODN was achieved without using any
cationic lipid or liposomal complex. Thereafter the decoy ODN-containing medium was removed, cells were washed twice with medium,
and then incubated in fresh medium containing the various test
compounds for the indicated periods of time. Decoy ODN treatment also
preceded transient transfection of the cultured SMC with the
aforementioned reporter gene constructs.
Staining of Nuclear DNA with H 33342. After termination of the incubation period, SMC were washed twice with HBSS and then incubated with fixation buffer (5% formaldehyde in 145 mM NaCl, 10 mM Hepes × KOH, pH 7.5) for 20 min at room temperature. After this period the fluorescent bisbenzimide dye H 33342 (Calbiochem, Bad Soden, Germany) was added at a final concentration of 10 µg/ml and the cells were incubated for a second period of 20 min. Thereafter, the buffer was replaced by 50% glycerol in HBSS, and the fixed cells were examined by using a video imaging system (Visitron, München, Germany). Nuclear staining intensity and morphology were evaluated optically and documented by using the MetaMorph V3.0 software package (Universal Imaging Co., West Chester, PA).
Data Analysis. Unless indicated otherwise, results are expressed as mean ± S.E.M. of n observations. Student's unpaired t test was used to determine differences between the means with a P value <0.05 considered to be statistically significant.
| |
Results |
|---|
|
|
|---|
ETB-R Expression.
In aortic and mesenteric SMC
grown on either plain plastic, fibronectin, gelatin, or collagen, basal
ETB-R mRNA levels were either not (Fig. 1,
a and b) or only hardly detectable (Fig.
1c). Tumor necrosis factor
(TNF
; 1000 U/ml), interleukin-1
(IL-1
; 60 U/ml) or interferon-
(IFN
; 200 U/ml) alone or in
combination (Fig. 1a) failed to induce ETB-R expression.
This was also the case when the aortic SMC had been isolated
enzymatically instead of using the explant technique (not shown). The
cytokines, on the other hand, especially when combined, significantly
enhanced the expression of other gene products, such as iNOS and VCAM-1 mRNA (Fig. 2), in the cultured SMC.
Moreover, in endothelium-intact or denuded ring segments of the rat
aorta (i.e., native endothelial and smooth muscle cells), there was
also no increase in ETB-R mRNA abundance following 6 h
of exposure to the cytokines (not shown).
|
|
B activation (Schreck et al.,
1992
plus IL-1
(1 h of
preincubation with PDTC before addition of the cytokines; Fig.
3). No difference could be detected in
the ability of PDTC to stimulate ETB-R expression
in either type of SMC or in the native SMC. Moreover, the protein
kinase C inhibitor, RO 31-8220 (0.1 µM), had no effect on
PDTC-stimulated ETB-R expression (not shown).
|
Transcription Factor Activation.
EMSA of nuclear extracts
prepared from the cultured SMC after 90 min of exposure to 100 µM
PDTC alone revealed a significant increase in the amount of AP-1, two
members of the C/EBP family of transcription factors, C/EBP
and
-
, and of GATA-2 in the nucleus (Fig.
4). Addition of PDTC to the SMC 1 h
before IL-1
and TNF
only slightly attenuated the
cytokine-stimulated translocation of NF-
B to the nucleus, whereas
the activity of both AP-1 and C/EBP was enhanced in response to this
agent. Interestingly, PDTC at this concentration almost completely
inhibited NF-
B activation in the presence of TNF
plus IFN
(Krzesz et al., 1999
). Cytokine-stimulated GATA-2 transfer to the
nucleus, on the other hand, was modestly attenuated in the presence of
PDTC (Fig. 4). Supershift analysis (Fig.
5) revealed two GATA-2-specific
DNA-protein complexes in the nuclear extracts of the SMC. Further
supershift analyses confirmed that PDTC enhanced mostly C/EBP
(Fig.
5), and that the two NF-
B-specific complexes consisted of the p65/50
heterodimer and the p50/50 homodimer (Krzesz et al., 1999
).
|
|
Effects of the Decoy ODN.
Pretreatment of the cultured SMC
with the AP-1, C/EBP, or GATA-2-specific decoy ODN individually reduced
PDTC-induced ETB-R expression to 51, 47, and 66% of the
stimulated control, respectively (Fig. 3). The NF-
B-specific decoy
ODN (Fig. 3b) and the AP-1 and C/EBP mutant decoy ODN, which were used
as controls, on the other hand, had no effect on PDTC-induced
ETB-R expression (Fig. 1c). According to EMSA, the decoy
ODNs were highly specific for their target transcription factor. Thus,
abundance of the target transcription factor was significantly reduced
in nuclear extracts prepared from cells treated with the corresponding
decoy ODN, whereas translocation of other transcription factors to the
nucleus was not affected (Fig. 6).
Moreover, pretreatment with the C/EBP consensus decoy ODN significantly
reduced cytokine-stimulated iNOS gene expression, which is thought to
be C/EBP-dependent (Eberhardt et al., 1998
), in the aortic SMC;
however, VCAM-1 gene expression, which is thought to be predominantly
NF-
B-dependent (Libby et al., 1995
), remained largely unaffected
(Fig. 2).
|
|
PDTC-Induced Expression of Functional ETB-R Protein.
To verify that the PDTC-induced rise in ETB-R mRNA
abundance was accompanied by a corresponding increase in receptor
protein, Western blot analyses with an
ETB-R-specific polyclonal antibody were
performed. A protein band of the expected molecular mass (43 kDa,
GenBank accession no. 111606) was detected that was up-regulated in
PDTC-treated cultured SMC to a variable extent (Fig.
8). Pretreatment of the cells with the
AP-1 consensus decoy ODN, but not with the corresponding mutant decoy
ODN, completely abrogated this PDTC-induced increase in
ETB-R protein (Fig. 8). In addition, the presence of
functional ETB-R protein was investigated by monitoring
ET-1-induced apoptosis of the SMC. The reason for choosing this
bioassay method was our recent observation of an enhanced rate of
apoptosis in rat aortic cultured SMC in the presence of exogenous ET-1
when ETB-R expression had been up-regulated by exposing the
cells to cyclic strain (Cattaruzza et al., 2000
). Previously,
ETB-R-mediated apoptosis was verified by flow cytometry,
chromatin condensation, DNA ladder formation, and caspase-3 activation;
for the present study we analyzed chromatin condensation only.
|
|
| |
Discussion |
|---|
|
|
|---|
The present findings demonstrate that in contrast to other
cytokine-inducible gene products (CD40, iNOS, monocyte chemoattractant protein-1, VCAM-1) ETB-R expression in rat
cultured SMC is not up-regulated in the presence of IFN
, IL-1
,
TNF
, or their combination. It was shown recently that
ETB-R expression in human umbilical vein
endothelial cells is significantly increased by TNF
when the cells
are grown on a fibrin matrix, but down-regulated in cells cultured on
plain plastic (Smith et al., 1998
). In the present study with SMC grown
on plastic, collagen, fibronectin, or gelatin-coated culture dishes we
observed either no effect on basal ETB-R
expression or a decrease in PDTC-stimulated ETB-R
mRNA expression by this and the two other cytokines. Moreover, there
was no cytokine-inducible ETB-R expression in
native endothelial and smooth muscle cells in situ (rat aorta); thus,
these cytokines are unlikely to play a role in
ETB-R induction in the rat vasculature.
The pyrrolidine derivative of dithiocarbamate, PDTC, is widely used as
an inhibitor of NF-
B activation in intact cells (Schreck et al.,
1992
). It is used as a tool to explore the expression of genes involved
in inflammatory processes, and an inhibitory effect of PDTC on gene
expression is usually linked exclusively to a prevention of NF-
B
activation. The present data clearly show that PDTC does not only
affect the activity of NF-
B but also that of other transcription
factors such as AP-1, C/EBP, and GATA-2. Moreover, recent findings from
our laboratory also demonstrate that PDTC inhibits the
IFN
-stimulated activation of Stat-1 in rat aortic cultured SMC
(Krzesz et al., 1999
). An activation by PDTC of AP-1 leading to an
increased expression of other gene products such as heme oxygenase-1
(Hartsfield et al., 1998
), manganese superoxide dismutase (Borrello and
Demple, 1997
), or intracellular adhesion molecule-1 (Munoz et al.,
1996
) has also been reported. These effects and that on
ETB-R expression, however, may not be related to
PDTC itself, but to thiuramdisulfides, the reactive metabolites of
these dithiocarbamates (Liu et al., 1998
).
The RNA synthesis inhibitor, actinomycin D, completely abolished
PDTC-stimulated ETB-R expression, suggesting that
PDTC increased the rate of transcription of the
ETB-R gene. To elucidate the transcriptional
mechanism by which PDTC up-regulated ETB-R
expression in the SMC, four transcription factors (i.e., AP-1, C/EBP,
NF-
B, and GATA-2) that we considered to be the most promising
candidates were investigated. AP-1 was the prime candidate because its
activation by PDTC had been described before (see above). In addition,
preproET-1 gene expression is regulated by transactivating signals that
depend on a cooperative interaction of GATA-2 and AP-1
cis-elements (Kawana et al., 1995
). We reasoned that if
expression of the endothelin system, as in the rat carotid artery
following PTCA (Wang et al., 1996
), is mediated by the same
transcription factors, then GATA-2 should also be a prime candidate.
Moreover, from parallel work in our laboratory on deformation-induced
expression of the ETB-R in rabbit blood vessels
(Lauth et al., 2000a
) C/EBP
or -
had emerged as another important
transcription factor. As judged by EMSA and corresponding supershift
analyses, PDTC indeed increased the abundance of C/EBP (in particular
that of C/EBP
), AP-1, and GATA-2 in nuclear extracts of the cultured
SMC. Both basal- and TNF
plus IL-1
-stimulated NF-
B activity,
on the other hand, were only moderately affected by PDTC, whereas
NF-
B activation by TNF
plus IFN
was strongly reduced (Krzesz
et al., 1999
).
Because the sequence of the 5'-flanking region of the rat
ETB-R gene is as yet unknown, we used consensus
decoy ODN to verify that the aforementioned three transcription factors
are responsible for the PDTC-induced up-regulation of
ETB-R transcription. Phosphorothiorate-modified oligonucleotides are fully resistant to almost all nucleases and have a
high biological stability (Monia et al., 1996
). Only after thoroughly
testing for their target specificity and optimization of both
preincubation time and concentration by EMSA were the decoy ODN used.
PDTC-stimulated ETB-R expression in the cultured SMC was indeed significantly decreased, albeit to a different degree
after exposure to the consensus decoy ODN against AP-1, C/EBP, or
GATA-2, but not when the corresponding mutant decoy ODN were used. The
NF-
B-specific decoy ODN, on the other hand, had no effect on
PDTC-induced ETB-R expression. The specificity of
the decoy ODN technique was further substantiated by reporter gene
analysis with an AP-1-driven preproendothelin-1 promoter luciferase
gene construct transiently transfected into the cultured SMC. These
reporter gene analyses also confirmed the PDTC-induced increase in AP-1
activity at the functional level.
On the basis of these findings we conclude that the enhanced
transcription of the ETB-R gene in rat cultured
SMC in the presence of PDTC is mediated by a PDTC-induced increase in
the activity of AP-1, C/EBP
, and GATA-2. This conclusion is
indirectly supported by the putative binding sites for transcription
factors that can be identified in the 5'-flanking region of the human
ETB-R gene (GenBank accession no. D13162), with
the reservation that there is indeed a sufficient homology between rat
and human ETB-R genes in the promoter region. By
using the MatInspector V2.2 software package (Quandt et al., 1995
), we
detected a potential binding site for GATA at
995 bp; three C/EBP
sites at
437,
348, and
59 bp; and four AP-1 sites at
706,
685,
369, and
201 bp. The 5'-flanking region of the human
ETB-R gene does not seem to contain a classical
TATA box or binding sites for NF-
B when scanned with the appropriate
stringency. The IL-1
/TNF
-mediated modest decrease in
PDTC-stimulated ETB-R expression, which could be
explained by the observed decrease in GATA-2 activity, also argues in
favor of an involvement of this transcription factor in
ETB-R gene expression.
Exposure of the cultured SMC to PDTC also resulted in an increase in
functional ETB-R protein, as verified by the BQ
788-sensitive, ET-1-induced increase in apoptosis. Such a pro-apoptotic
effect can also be observed in rat aortic cultured SMC exposed to
cyclic strain that is based on an activation of the
ETB-R but not the ETA-R
(Cattaruzza et al., 2000
), which predominates in these cells under
static conditions. One functional consequence of this
ETB-R-mediated apoptosis, which can also be
observed in native arterial but not venous SMC in situ (Lauth et al.,
2000a
), may be the remodeling of the vessel wall in response to a
pressure overload such as in restenosis following PTCA (Bennett, 1999
)
or arterial hypertension. Knowing the transcription factors that
mediate this pressure-induced increase in ETB-R
expression in the SMC may help to devise new strategies by which this
possibly deleterious adaptive response can be prevented.
In summary, the present findings demonstrate that in cultured SMC of
the aorta and mesenteric vascular bed of the rat,
ETB-R gene expression is up-regulated by PDTC.
This stimulation of ETB-R gene expression appears
to be mediated by the simultaneous activation of AP-1, C/EBP
, and
GATA-2. Although it is not clear how PDTC up-regulates transcription
factor activity, presumably by influencing the activity of certain
protein kinases and/or phosphatases, this effect may not be caused by
PDTC itself, but by the corresponding thiuramdisulfide metabolite.
Regardless of the precise mechanism of action of PDTC, this agent may
be used as a surrogate stimulus for the effects of cyclic strain on
gene expression in cultured SMC that also seems to be associated with
activation of a similar set of transcription factors. The highly
significant suppression of PDTC-stimulated ETB-R
expression by the corresponding decoy ODN finally verifies the
feasibility of the decoy ODN strategy for studying the transcriptional
regulation of disease-related genes in vitro and may contribute to the
development of new therapeutic concepts on this basis.
| |
Acknowledgments |
|---|
We thank Felicia Grimm, Nicole Gottlieb, and Renate Dohrmann for excellent technical assistance and Dr Manfred Lauth for performing the experiments with the endothelium-intact rat aortic segments.
| |
Footnotes |
|---|
Received January 10, 2000; Accepted June 29, 2000
1 On leave from the Department of Clinical Biochemistry, Jagiellonian University College of Medicine, ul. Kopernika 15a, 31-501 Krakow, Poland.
This work was supported by the Deutsche Forschungsgemeinschaft (project no. He 1587/7-1).
Send reprint requests to: Dr. Markus Hecker, Department of Cardiovascular Physiology, University of Goettingen, Humboldtallee 23, D-37073 Goettingen, Germany. E-mail: hecker{at}veg-physiol.med.uni-goettingen.de
| |
Abbreviations |
|---|
ET-1, -2, -3, endothelin-1, -2, -3;
SMC, smooth
muscle cells;
raSMC, rat aortic cultured SMC;
AP-1, activator
protein-1;
PDTC, pyrrolidine dithiocarbamate;
ETA-R, endothelin-A receptor;
ETB-R, endothelin-B receptor;
PTCA, percutaneous transluminal coronary angioplasty;
ODN, oligodeoxynucleotide(s);
dODN, decoy ODN;
EMSA, electrophoretic
mobility shift analysis;
FBS, fetal bovine serum;
HBSS, Hanks'
balanced salt solution;
MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl
tetrazolium bromide;
CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid;
RT-PCR, reverse transcriptase-polymerase chain reaction;
EF-2, elongation factor 2;
bp, base pair(s);
VCAM-1, vascular cell adhesion
molecule-1;
iNOS, inducible nitric-oxide synthase;
C/EBP, CCAAT/enhancer-binding protein;
NF-
B, nuclear factor
B;
PMA, phorbol 12-myristate 13-acetate;
TNF
, tumor necrosis factor
;
IL-1
, interleukin-1
;
IFN
, interferon-
.
| |
References |
|---|
|
|
|---|
B-independent transcriptional induction of the human manganous superoxide dismutase gene.
Arch Biochem Biophys
348:
289-294[Medline].
and cAMP in rat mesangial cells.
J Immunol
160:
4961-4969
B and signal transducer and activation of transcription-1.
FEBS Lett
453:
191-196[Medline].
B activation in intact cells.
J Exp Med
175:
1181-1194This article has been cited by other articles:
![]() |
A. Tiran, H.-J. Gruber, W. F. Graier, A. H. Wagner, E. B.M. van Leeuwen, and B. Tiran Aspirin Inhibits Chlamydia pneumoniae-Induced Nuclear Factor-{kappa}B Activation, Cytokine Expression, and Bacterial Development in Human Endothelial Cells Arterioscler. Thromb. Vasc. Biol., July 1, 2002; 22(7): 1075 - 1080. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Wagner, M. Gebauer, B. Pollok-Kopp, and M. Hecker Cytokine-inducible CD40 expression in human endothelial cells is mediated by interferon regulatory factor-1 Blood, January 15, 2002; 99(2): 520 - 525. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. WAGNER, M. R. SCHROETER, and M. HECKER 17{beta}-Estradiol inhibition of NADPH oxidase expression in human endothelial cells FASEB J, October 1, 2001; 15(12): 2121 - 2130. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Cattaruzza, I. Eberhardt, and M. Hecker Mechanosensitive Transcription Factors Involved in Endothelin B Receptor Expression J. Biol. Chem., September 28, 2001; 276(40): 36999 - 37003. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||